Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Mark J. Hamblin"'
Autor:
Ganesh Raghu, Mark J. Hamblin, A. Whitney Brown, Jeffrey A. Golden, Lawrence A. Ho, Marlies S. Wijsenbeek, Martina Vasakova, Alberto Pesci, Danielle E. Antin-Ozerkis, Keith C. Meyer, Michael Kreuter, Tracy Burgess, Nikhil Kamath, Francis Donaldson, Luca Richeldi
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Recombinant human pentraxin-2 (rhPTX-2) significantly decreased decline in percent predicted forced vital capacity (FVC) and stabilized 6-min walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF) during the 28-
Externí odkaz:
https://doaj.org/article/2c195c019cfe4de6992fd1e22d59cc6f
Autor:
Mark J. Hamblin, Maureen R. Horton
Publikováno v:
Pulmonary Medicine, Vol 2011 (2011)
Interstitial lung disease (ILD) is an increasingly recognized complication of rheumatoid arthritis (RA) contributing to significantly increased morbidity and mortality. Diagnosis can be challenging since patients are unlikely to report dyspnea due to
Externí odkaz:
https://doaj.org/article/9f8998b6a16b48cfb5936487287936ff
Publikováno v:
Immunology and Allergy Clinics of North America. 43:245-257
Autor:
Ganesh Raghu, Majd Mouded, Daniel C. Chambers, Fernando J. Martinez, Luca Richeldi, Lisa H. Lancaster, Mark J. Hamblin, Kevin F. Gibson, Ivan O. Rosas, Antje Prasse, Guolin Zhao, Michael Serenko, Natasha Novikov, Amy McCurley, Prashant Bansal, Christopher Stebbins, Million Arefayene, Stella Ibebunjo, Shelia M. Violette, Diana Gallagher, Jürgen Behr
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 206:1128-1139
Publikováno v:
The American Journal of Managed Care. 27:S147-S154
Progressive fibrosing interstitial lung diseases (ILDs) encompass a wide range of diseases, including hypersensitivity pneumonitis, occupational diseases, granulomatous diseases, drug-induced diseases, and idiopathic pneumonitis. Given the vast numbe
Autor:
Ganesh Raghu, Mark J. Hamblin, A. Whitney Brown, Jeffrey A. Golden, Lawrence A. Ho, Marlies S. Wijsenbeek, Martina Vasakova, Alberto Pesci, Danielle E. Antin-Ozerkis, Keith C. Meyer, Michael Kreuter, Tracy Burgess, Nikhil Kamath, Francis Donaldson, Luca Richeldi
Publikováno v:
Respiratory Research, 23(1):129. BioMed Central Ltd.
Background Recombinant human pentraxin-2 (rhPTX-2) significantly decreased decline in percent predicted forced vital capacity (FVC) and stabilized 6-min walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF) during the 28-week, pla
Autor:
A. Whitney Brown, Renu Gupta, Ganesh Raghu, Luca Richeldi, Mark J. Hamblin, Lawrence A. Ho, Marlies S. Wijsenbeek, Bernt van den Blink, Jeffrey A. Golden, Hugues Santin-Janin, Michael Kreuter, Geert-Jan Mulder, Martina Vasakova, Danielle Antin-Ozerkis, Francois Aubin, Keith C. Meyer, Donna Moran, Alberto Pesci
Publikováno v:
The Lancet Respiratory Medicine, 7(8), 657-664. Elsevier Ltd.
Background: Patients with idiopathic pulmonary fibrosis (IPF) treated with PRM-151, a recombinant human pentraxin 2 protein, in a phase 2 double-blind, randomised controlled trial had significantly reduced decline in percentage of predicted forced vi
Publikováno v:
Kansas Journal of Medicine
Myocarditis is defined as inflammation targeting the heart muscle. Autoimmune myocarditis is a subtype of myocarditis that can occur as an isolated entity in which the primary targeted organ is the heart or as part of a systemic autoimmune disease. T
Publikováno v:
Cureus
Background Interstitial lung disease (ILD) is a common pathologic consequence of the idiopathic inflammatory myopathies, and it may be the initial presentation of autoimmune disease in many cases. There are no well-established guidelines to direct th
Autor:
Valay Parikh, Mark J. Hamblin, Luigi Di Biase, Dhanunjaya Lakkireddy, Sanghamitra Mohanty, Sudharani Bommana, Heidi Carroll, Mohit K. Turagam, Donita Atkins, Thomas Rosamond, Megan Krause, Tawseef Dar, Cheri Nydegger, Bharath Yarlagadda, Andrea Natale, Rakesh Gopinathannair, Louis Wetzel
Publikováno v:
Circulation: Arrhythmia and Electrophysiology. 12
Background: Premature ventricular contractions are a common clinical presentation that drives further diagnostic workup. We hypothesize the presence of underlying inflammation is often unrecognized in these patients with a potential for continued dis